Hilar cholangiocarcinoma
Showing 1 - 25 of 464
Perihilar Cholangiocarcinoma Trial in Padova (Liver transplantation)
Not yet recruiting
- Perihilar Cholangiocarcinoma
- Liver transplantation
-
Padova, ItalyAzienda Ospedale Università di Padova
Nov 5, 2023
EUS-FNA/B Versus ERCP With or Without POCS-TB in Suspected Hilar
Not yet recruiting
- Klatskin Tumor
- +3 more
- The sampling method selected in patients with suspected hilar cholangiocarcinoma
-
Jinan, Shandong, ChinaQilu Hospital of Shandong University
Aug 14, 2023
Lymph Node Metastasis Status of Hilar Cholangiocarcinoma
Recruiting
- Hilar Cholangiocarcinoma
- No interventions
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 16, 2022
Cholangiocarcinoma, Hilar, Biliary Stricture, Hilar Cholangiocarcinoma Trial in Hangzhou (Endoscopic nasobiliary duct cutting,
Recruiting
- Cholangiocarcinoma, Hilar
- +6 more
- Endoscopic nasobiliary duct cutting
- Bilateral plastic stent
-
Hangzhou, Zhejiang, ChinaHangzhou First People's Hospital
Oct 24, 2023
Hilar Cholangiocarcinoma, Biliary Obstruction Trial in Bangkok (ELRA endoluminal radiofrequency ablation electrode (Taewoong,
Completed
- Hilar Cholangiocarcinoma
- Biliary Obstruction
- ELRA endoluminal radiofrequency ablation electrode (Taewoong, Seoul, Korea)
-
Bangkok, ThailandRajavithi Hospital
Mar 22, 2022
Hilar Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma, Common Bile Duct Tumors Trial in Rotterdam (Endoscopic Ultrasound
Recruiting
- Hilar Cholangiocarcinoma
- +4 more
- Endoscopic Ultrasound registration
-
Rotterdam, Zuid-Holland, NetherlandsErasmus University Medical Center
Jan 11, 2023
Hilar Cholangiocarcinoma Trial in Leipzig (Photosensitizer, Radiofrequency ablation (RFA))
Recruiting
- Hilar Cholangiocarcinoma
- Photosensitizer
- Radiofrequency ablation (RFA)
-
Leipzig, GermanyUniversity Hospital of Leipzig, Department of Gastroenterology
Oct 14, 2022
Multi-Platform Profiling of Resected Biliary Tract Cancer
Recruiting
- Biliary Tract Cancer
- +7 more
- Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring
-
Chicago, Illinois
- +1 more
Jan 23, 2023
Cholangiocarcinoma Trial in Villejuif (CAPECITABINE-Radiotherapy -Liver Transplantation, RESECTION)
Active, not recruiting
- Cholangiocarcinoma
- CAPECITABINE-Radiotherapy -Liver Transplantation
- RESECTION
-
Villejuif, FranceAP-HP, Paul Brousse Hospital, Centre Hepato-Biliaire
Nov 2, 2021
Cholangitis Trial in Lanzhou, Xi'an, Tianjin (Injection of 37? contrast agent)
Recruiting
- Cholangitis
- Injection of 37℃ contrast agent
-
Lanzhou, Gansu, China
- +2 more
Nov 18, 2021
Hilar Cholangiocarcinoma Trial in Xuzhou (I-125 seeds loaded stent (self-expanded metal stent with I-125 seeds, Micro-Tech,
Enrolling by invitation
- Hilar Cholangiocarcinoma
- I-125 seeds loaded stent (self-expanded metal stent with I-125 seeds, Micro-Tech, Nanjing, China)
- Normal stent (self-expanded metal stent without I-125 seeds, Micro-Tech, Nanjing, China)
-
Xuzhou, Jiangsu, ChinaXuzhou Central Hospital
Jul 12, 2021
Biliary Tract Cancer (CCA), Intrahepatic Cholangiocarcinoma, Hilar Cholangiocarcinoma Trial in Frankfurt am Main (Durvalumab,
Recruiting
- Biliary Tract Cancer (CCA)
- +4 more
- Durvalumab
- +2 more
-
Frankfurt am Main, GermanyKrankenhaus Nordwest
Jun 23, 2022
Nutritional Status for Surgical Peri Hilar Cholangiocarcinoma
Recruiting
- Perihilar Cholangiocarcinoma
- Nutritional evaluation
-
Vandœuvre-lès-Nancy, FranceCHRU de Nancy
Apr 12, 2021
Recurrent Biliary Tract Carcinoma, Recurrent Distal Bile Duct Adenocarcinoma, Recurrent Gallbladder Carcinoma Trial
Not yet recruiting
- Recurrent Biliary Tract Carcinoma
- +13 more
- Binimetinib
- +10 more
- (no location specified)
Nov 8, 2022
Unresectable Hilar Cholangiocarcinoma Trial in Nanjing (REMS+TAI, SEMS+TAI)
Not yet recruiting
- Unresectable Hilar Cholangiocarcinoma
- REMS+TAI
- SEMS+TAI
-
Nanjing, Jiangsu, ChinaZhongda Hospital,Southeast University
Mar 15, 2021
Hilar Cholangiocarcinoma Trial in Groningen (Bevacizumab-IRDye800CW, near infrared (NIR) fluorescence imaging)
Recruiting
- Hilar Cholangiocarcinoma
- Bevacizumab-IRDye800CW
- near infrared (NIR) fluorescence imaging
-
Groningen, NetherlandsUniversity Medical Center Groningen
Apr 27, 2021
Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma, Determine Efficacy of Liver Transplantation After Neoadjuvant
Not yet recruiting
- Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma
- Determine Efficacy of Liver Transplantation After Neoadjuvant Systemic Therapy in Patients With Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma
- Liver Transplant
-
Newark, New Jersey
- +1 more
Nov 14, 2023
Hilar Cholangiocarcinoma Trial in Xi'an (bilateral metal stent insertion, unilateral metal stent insertion)
Unknown status
- Hilar Cholangiocarcinoma
- bilateral metal stent insertion
- unilateral metal stent insertion
-
Xi'an, Shanxi, ChinaHan Guo Hong
Jul 31, 2019
Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma
Recruiting
- Cholangiocarcinoma
- Observation data collection study.
-
Saint Louis, MissouriWashington University School of Medicine
Jul 28, 2022
Nab-paclitaxel Plus Gemcitabine-cisplatin Chemotherapy in
Not yet recruiting
- Locally Advanced Cholangiocarcinoma
-
Seongnam-si, Gyeonggi-do, Korea, Republic ofCHA Bundang Medical Center
Jan 24, 2023
Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Seongnam-si (nab-paclitaxel plus gemcitabine-cisplatin)
Recruiting
- Biliary Tract Cancer
- +2 more
- nab-paclitaxel plus gemcitabine-cisplatin
-
Seongnam-si, Gyeonggi-do, Korea, Republic ofCHA Bundang Medical Center
Oct 27, 2022
Endoscopic Retrograde Cholangiopancreatography, Klatskin Tumor Trial in Shanghai (Endoscopic scissors, Biliary stent)
Withdrawn
- Endoscopic Retrograde Cholangiopancreatography
- Klatskin Tumor
- Endoscopic scissors
- Biliary stent
-
Shanghai, Shanghai, ChinaDepartment of Gastroenterology, Changhai Hospital, Second Milita
Aug 22, 2022
Cholangiocarcinoma Trial in Navi Mumbai (High Dose Radiation, Systemic chemo)
Recruiting
- Cholangiocarcinoma
- High Dose Radiation
- Systemic chemotherapy
-
Navi Mumbai, Maharashtra, IndiaAdvanced Centre of Treatment Research and Education In Cancer,Ta
Oct 20, 2022
Intrahepatic Cholangiocarcinoma Trial in Tianjin (Regorafenib and HAIC, FOLFOX)
Not yet recruiting
- Intrahepatic Cholangiocarcinoma
- Regorafenib and HAIC
- FOLFOX
-
Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Sep 7, 2022